Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Hemostats
      • 1.3.3 Internal Tissue Sealants
      • 1.3.4 Adhesion Barriers
    • 1.4 Market Segment by Application
      • 1.4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics & Trauma Centers
      • 1.4.4 Ambulatory Surgical Centers
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value 2014-2025
      • 2.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production 2014-2025
      • 2.1.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Capacity 2014-2025
      • 2.1.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size CAGR of Key Regions
      • 2.2.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Capacity by Manufacturers
      • 3.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Manufacturers (2014-2019)
      • 3.2.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Concentration Ratio (CR5 and HHI)
    • 3.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price by Manufacturers
    • 3.4 Key Manufacturers Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
    • 3.6 Key Manufacturers Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Hemostats Production and Production Value (2014-2019)
      • 4.1.2 Internal Tissue Sealants Production and Production Value (2014-2019)
      • 4.1.3 Adhesion Barriers Production and Production Value (2014-2019)
    • 4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Market Share by Type
    • 4.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value Market Share by Type
    • 4.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Application

    6 Production by Regions

    • 6.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production (History Data) by Regions 2014-2019
    • 6.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Growth Rate 2014-2019
      • 6.3.2 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Growth Rate 2014-2019
      • 6.4.2 European Union Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import & Export
    • 6.5 China
      • 6.5.1 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Growth Rate 2014-2019
      • 6.5.2 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Regions

    • 7.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Type
      • 7.2.2 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Type
      • 7.3.2 European Union Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Application
    • 7.4 China
      • 7.4.1 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Type
      • 7.4.2 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Type
      • 7.5.2 Rest of World Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Baxter
      • 8.1.1 Baxter Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.1.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.1.5 Baxter Recent Development
    • 8.2 Ethicon
      • 8.2.1 Ethicon Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.2.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.2.5 Ethicon Recent Development
    • 8.3 B. Braun Melsungen
      • 8.3.1 B. Braun Melsungen Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.3.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.3.5 B. Braun Melsungen Recent Development
    • 8.4 Sanofi
      • 8.4.1 Sanofi Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.4.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.4.5 Sanofi Recent Development
    • 8.5 C. R. Bard
      • 8.5.1 C. R. Bard Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.5.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.5.5 C. R. Bard Recent Development
    • 8.6 Integra Lifesciences
      • 8.6.1 Integra Lifesciences Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.6.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.6.5 Integra Lifesciences Recent Development
    • 8.7 Cryolife
      • 8.7.1 Cryolife Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.7.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.7.5 Cryolife Recent Development
    • 8.8 Tissuemed
      • 8.8.1 Tissuemed Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.8.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.8.5 Tissuemed Recent Development
    • 8.9 Cohera Medical
      • 8.9.1 Cohera Medical Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.9.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.9.5 Cohera Medical Recent Development
    • 8.10 Pfizer
      • 8.10.1 Pfizer Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
      • 8.10.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Introduction
      • 8.10.5 Pfizer Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Forecast by Type
      • 9.7.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales Channels
      • 10.2.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Distributors
    • 10.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Increasing geriatric population across the globe coupled with increasing demand for cardiovascular, orthopaedic, digestive, and other surgical procedures is expected to fuel consumption of surgical hemostats, internal tissue sealants and adhesion barriers market.
      Primary factors fuelling demand for surgical hemostats, internal tissue sealants and adhesion barriers are rapidly ageing population with rising cardiovascular, digestive, orthopaedic and other surgical procedures, strong healthcare consciousness and availability of new surgical adhesives for various surgical application.
      In 2019, the market size of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers.

      This report studies the global market size of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Baxter
      Ethicon
      B. Braun Melsungen
      Sanofi
      C. R. Bard
      Integra Lifesciences
      Cryolife
      Tissuemed
      Cohera Medical
      Pfizer

      Market Segment by Product Type
      Hemostats
      Internal Tissue Sealants
      Adhesion Barriers

      Market Segment by Application
      Hospitals
      Clinics & Trauma Centers
      Ambulatory Surgical Centers

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now